FARALLON CAPITAL MANAGEMENT LLC - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 114 filers reported holding ALBIREO PHARMA INC in Q3 2020. The put-call ratio across all filers is 7.29 and the average weighting 0.2%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q2 2021$8,795,000
-0.2%
250,0000.0%0.04%
-18.2%
Q1 2021$8,813,000
-6.0%
250,0000.0%0.04%
-21.4%
Q4 2020$9,378,000
+40.5%
250,000
+25.0%
0.06%
+21.7%
Q3 2020$6,674,000200,0000.05%
Other shareholders
ALBIREO PHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Prosight Management, LP 330,407$5,409,0002.53%
Perceptive Advisors 1,960,139$31,931,0000.83%
Birchview Capital, LP 48,000$786,0000.70%
Chicago Capital, LLC 492,878$8,068,0000.65%
Artal Group S.A. 588,125$9,628,0000.41%
PA Capital LLC 23,198$380,0000.34%
Eversept Partners, LP 78,029$1,277,3350.32%
HEARTLAND ADVISORS INC 150,000$2,456,0000.26%
ArrowMark Colorado Holdings LLC 972,372$15,918,0000.21%
KETTLE HILL CAPITAL MANAGEMENT, LLC 25,268$414,0000.14%
View complete list of ALBIREO PHARMA INC shareholders